Search

Moderna announced that the European Commission, EC, has granted marketing authorization for mRESVIA, an mRNA respiratory syncytial virus vaccine, to protect adults aged 60 years and older from lower respiratory [...]

Moderna announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the granting of marketing authorization in the European Union for [...]

Pfizer announced that the European Commission, or EC, has granted marketing authorization for the company's 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name Prevenar 20, [...]

Novavax said it has been granted full marketing authorization by the European Commission in the European Union for Nuvaxovid. The vaccine is now fully authorized for use as a primary [...]

Moderna announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional marketing authorization for Spikevax bivalent Original/Omicron BA.1, the company's [...]

Novavax announced that the Medicines and Healthcare products Regulatory Agency in the United Kingdom has granted expanded conditional marketing authorization for Nuvaxovid COVID-19 vaccine for active immunization to prevent COVID-19 [...]

Valneva announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended marketing authorization in Europe for Valneva's inactivated whole-virus COVID-19 vaccine candidate, VLA2001, [...]

VBI Vaccines announced that the UK Medicines and Healthcare Products Regulatory Agency, or MHRA, has granted marketing authorization for PreHevbri for active immunization against infection caused by all known subtypes [...]

VBI Vaccines announced that the European Commission, or EC, has granted marketing authorization for PreHevbri or active immunisation against infection caused by all known subtypes of the hepatitis B virus, [...]

Novavax announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted Novavax conditional marketing authorization for Nuvaxovid COVID-19 Vaccine for active immunization to prevent COVID-19 caused by SARS-CoV-2 in [...]

Argus analyst John Staszak raised the firm's price target on Hilton to $154 from $145 and keeps a Buy rating on the shares. The continued rollout of COVID vaccines should [...]

Argus analyst John Staszak lowered the firm's price target on Peloton to $120 from $180 but keeps a Buy rating on the shares. The company has seen strong demand during [...]

Mizuho analyst Ann Hynes raised the firm's price target on CVS Health to $98 from $82 and keeps a Buy rating on the shares. The analyst continues to expect the [...]

Stifel analyst Steven Wieczynski raised the firm's price target on Royal Caribbean to $62 from $52 after hosting investor meetings with CFO Jason Liberty. Based on early-2021 booking trends, management [...]